ArticleBMC cancer2022

Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: a retrospective study.

Xiaodong Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.